LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target

被引：4
|
作者：
Li, Yijie [1 ,2 ,3 ,4 ,5 ]
Liu, Fenglin [6 ]
Cai, Yunzhou [1 ,2 ,3 ,4 ,5 ]
Yang, Yanqing [1 ,2 ,3 ,4 ,5 ]
Wang, Yuehong [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Cent South Univ, Hunan Key Lab Oral Hlth Res, Changsha 410008, Peoples R China
[2] Cent South Univ, Hunan 3D Printing Engn Res Ctr Oral Care, Changsha 410008, Peoples R China
[3] Cent South Univ, Hunan Clin Res Ctr Oral Major Dis & Oral Hlth, Changsha 410008, Peoples R China
[4] Cent South Univ, Academician Workstn Oral Maxillofacial & Regenera, Changsha 410008, Peoples R China
[5] Cent South Univ, Xiangya Sch Stomatol, Changsha 410008, Peoples R China
[6] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410013, Peoples R China
来源：
CRYSTALS | 2021年 / 11卷 / 03期
基金：
中国国家自然科学基金;
关键词：
fibrosis; long noncoding RNAs; MALAT1; pathogenic mechanism; LONG NONCODING RNA; TO-MESENCHYMAL TRANSITION; INDUCED INTERSTITIAL FIBROSIS; METABOLOMICS; INJURY; INFLAMMATION; SUPPRESSION; DYSFUNCTION; MECHANISMS; REGULATOR;
D O I：
10.3390/cryst11030249
中图分类号：
O7 [晶体学];
学科分类号：
0702 ; 070205 ; 0703 ; 080501 ;
摘要：
Due to the lack of an effective method for the treatment of fibrosis, there are numerous patients suffering from the effects of fibrosis. Severe fibrosis can cause dysfunction of relevant organs characterized by excessive deposition of extracellular matrix components. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA that is widely expressed and highly conserved in human tissues. It can regulate gene expression at various molecular levels, involved in the fibrosis of the liver, heart, lung, and kidney. In this review, we first described the pathogenesis by which MALAT1 promotes fibrosis. Furthermore, we summarized current studies of MALAT1 in the fibrosis of various organs. Hope this review will contribute to a better understanding of the molecular mechanism of fibrosis and the potential of MALAT1 as a novel therapeutic target for fibrosis.
引用
收藏
页码：1 / 16
页数：16
相关论文
共 50 条
  • [31] The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target
    Jiang, Xiaoying
    Ning, Qilan
    MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 188
  • [32] MALAT1 as a Diagnostic and Therapeutic Target in Diabetes-Related Complications: A Promising Long-Noncoding RNA
    Abdulle, Leila Elmi
    Hao, Ji-long
    Pant, Om Prakash
    Liu, Xiu-fen
    Zhou, Dan-dan
    Gao, Ying
    Suwal, Abhishek
    Lu, Cheng-wei
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (04): : 548 - 555
  • [33] MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complications
    Prasanth Puthanveetil
    Tony Gutschner
    Johan Lorenzen
    Hypertension Research, 2020, 43 : 372 - 379
  • [34] lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells
    Cao, Chen
    Zhen, Wei
    Yu, Haibin
    Zhang, Li
    Liu, Yiling
    OPEN LIFE SCIENCES, 2021, 16 (01): : 1303 - 1312
  • [35] Natural antisense RNA promotes 3' end processing and maturation of MALAT1 lncRNA
    Zong, Xinying
    Nakagawa, Shinichi
    Freier, Susan M.
    Fei, Jingyi
    Ha, Taekjip
    Prasanth, Supriya G.
    Prasanth, Kannanganattu V.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (06) : 2898 - 2908
  • [36] The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury
    Wang, Liping
    Li, Sijie
    Stone, Sara Saymuah
    Liu, Na
    Gong, Kerui
    Ren, Changhong
    Sun, Kai
    Zhang, Chunyang
    Shao, Guo
    BIOMOLECULES, 2022, 12 (01)
  • [37] Expression and Prognostic Significance of lncRNA MALAT1 in Pancreatic Cancer Tissues
    Liu, Jiang-Hua
    Chen, Gang
    Dang, Yi-Wu
    Li, Chun-Jun
    Luo, Dian-Zhong
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 2971 - 2977
  • [38] LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
    Zhou, Qinfeng
    Tang, Xinyi
    Tian, Xinyu
    Tian, Jie
    Zhang, Yue
    Ma, Jie
    Xu, Huaxi
    Wang, Shengjun
    JOURNAL OF CANCER, 2018, 9 (14): : 2436 - 2442
  • [39] Targeting lncRNA MALAT1: A Promising Approach to Overcome Metabolic Syndrome
    Aihemaiti, Gulandanmu
    Song, Ning
    Luo, Junyi
    Liu, Fen
    Toyizibai, Jianaerguli
    Adili, Niyaziaili
    Liu, Chang
    Ji, Wei
    Yang, Yi-Ning
    Li, Xiaomei
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [40] LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
    Yuhang Xiao
    Ta Xiao
    Wei Ou
    Zhining Wu
    Jie Wu
    Jinming Tang
    Bo Tian
    Yong Zhou
    Min Su
    Wenxiang Wang
    Biomarker Research, 8
12345